Fulcrum Asset Management LLP Sells 4,638 Shares of UnitedHealth Group Incorporated $UNH

Fulcrum Asset Management LLP decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 35.5% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 8,441 shares of the healthcare conglomerate’s stock after selling 4,638 shares during the period. Fulcrum Asset Management LLP’s holdings in UnitedHealth Group were worth $2,915,000 as of its most recent SEC filing.

A number of other large investors have also recently modified their holdings of the business. Sagard Holdings Management Inc. bought a new position in shares of UnitedHealth Group in the second quarter worth approximately $29,000. Foster Dykema Cabot & Partners LLC grew its stake in UnitedHealth Group by 69.4% in the 3rd quarter. Foster Dykema Cabot & Partners LLC now owns 83 shares of the healthcare conglomerate’s stock worth $29,000 after buying an additional 34 shares in the last quarter. 1248 Management LLC bought a new position in shares of UnitedHealth Group in the 3rd quarter worth $29,000. Hurley Capital LLC lifted its holdings in shares of UnitedHealth Group by 81.6% during the 3rd quarter. Hurley Capital LLC now owns 89 shares of the healthcare conglomerate’s stock worth $31,000 after acquiring an additional 40 shares during the last quarter. Finally, Cloud Capital Management LLC bought a new position in UnitedHealth Group in the third quarter valued at $32,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 1.2%

Shares of UNH opened at $284.03 on Thursday. The firm has a fifty day simple moving average of $299.84 and a two-hundred day simple moving average of $324.69. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $606.36. The stock has a market capitalization of $257.81 billion, a P/E ratio of 21.53, a PEG ratio of 1.32 and a beta of 0.41. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.72.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, January 27th. The healthcare conglomerate reported $2.11 EPS for the quarter, beating the consensus estimate of $2.09 by $0.02. UnitedHealth Group had a net margin of 2.69% and a return on equity of 14.79%. The firm had revenue of $113.73 billion during the quarter, compared to the consensus estimate of $113.38 billion. During the same period in the prior year, the firm posted $6.81 earnings per share. The company’s quarterly revenue was up 12.3% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. On average, research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 17th. Stockholders of record on Monday, March 9th were paid a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, March 9th. This represents a $8.84 annualized dividend and a dividend yield of 3.1%. UnitedHealth Group’s payout ratio is 67.02%.

Analyst Ratings Changes

A number of research firms have recently issued reports on UNH. Barclays cut their price objective on UnitedHealth Group from $391.00 to $327.00 and set an “overweight” rating for the company in a report on Friday, January 30th. Oppenheimer dropped their target price on UnitedHealth Group from $415.00 to $385.00 and set an “outperform” rating for the company in a research report on Wednesday, January 28th. Leerink Partners decreased their price target on shares of UnitedHealth Group from $410.00 to $345.00 and set an “outperform” rating on the stock in a research note on Wednesday, January 28th. Sanford C. Bernstein reaffirmed an “outperform” rating on shares of UnitedHealth Group in a research note on Wednesday, January 28th. Finally, Mizuho lowered their price target on shares of UnitedHealth Group from $430.00 to $350.00 and set an “outperform” rating for the company in a research note on Thursday, February 5th. One analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating, eight have assigned a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat.com, UnitedHealth Group has an average rating of “Moderate Buy” and a consensus price target of $372.13.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.